Rifampicin
- Oral / IVRifampicinRifadin
Mechanism of Action
- Inhibit bacterial RNA polymerase, resulting in disruption of DNA transcription.
Microbiology
- Active against gram positive bacteria and Mycobacterium species.
Clinical Use
- Indications
- Mycobacteria - tuberculosis, Mycobacterium avium complex (MAC), leprosy
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Adverse Effects
- Orange discolouration of bodily fluids
- Hepatitis
- Reflux